ASX - By Stock
|
CDD |
Re:
Thoughts moving forward?
|
|
sailnyssa
|
6 |
3.6K |
2 |
25/06/21 |
25/06/21 |
ASX - By Stock
|
6
|
3.6K
|
2
|
|
ASX - By Stock
|
CDD |
Re:
Ann: Daily share buy-back notice - Appendix 3E
|
|
sailnyssa
|
5 |
1.8K |
2 |
26/04/21 |
26/04/21 |
ASX - By Stock
|
5
|
1.8K
|
2
|
|
General
|
Oil & Gas |
Re:
transocean - deepwater horizon
|
|
sailnyssa
|
103 |
32K |
1 |
24/03/21 |
24/03/21 |
General
|
103
|
32K
|
1
|
|
ASX - By Stock
|
CDD |
Re:
Ann: HY21 Results Investor Presentation
|
|
sailnyssa
|
29 |
13K |
2 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
29
|
13K
|
2
|
|
ASX - By Stock
|
CDD |
Re:
Ann: HY21 Results Investor Presentation
|
|
sailnyssa
|
29 |
13K |
2 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
29
|
13K
|
2
|
|
ASX - By Stock
|
CCX |
Re:
Ann: FY21 Interim Results Presentation
|
|
sailnyssa
|
5 |
2.5K |
0 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
5
|
2.5K
|
0
|
|
ASX - By Stock
|
CDD |
Re:
CDD -- The Next Two Years
|
|
sailnyssa
|
32 |
10K |
1 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
32
|
10K
|
1
|
|
ASX - By Stock
|
CDD |
Re:
CDD -- The Next Two Years
|
|
sailnyssa
|
32 |
10K |
1 |
05/01/21 |
05/01/21 |
ASX - By Stock
|
32
|
10K
|
1
|
|
ASX - By Stock
|
CDD |
Re:
CDD -- The Next Two Years
|
|
sailnyssa
|
32 |
10K |
2 |
05/01/21 |
05/01/21 |
ASX - By Stock
|
32
|
10K
|
2
|
|
ASX - By Stock
|
CDD |
Re:
CDD -- The Next Two Years
|
|
sailnyssa
|
32 |
10K |
3 |
05/01/21 |
05/01/21 |
ASX - By Stock
|
32
|
10K
|
3
|
|
General
|
Oil & Gas |
Re:
transocean - deepwater horizon
|
|
sailnyssa
|
103 |
32K |
0 |
02/01/21 |
02/01/21 |
General
|
103
|
32K
|
0
|
|
ASX - By Stock
|
CDD |
Re:
CDD -- The Next Two Years
|
|
sailnyssa
|
32 |
10K |
4 |
02/01/21 |
02/01/21 |
ASX - By Stock
|
32
|
10K
|
4
|
|
ASX - By Stock
|
CDD |
Re:
CDD -- The Next Two Years
|
|
sailnyssa
|
32 |
10K |
4 |
02/01/21 |
02/01/21 |
ASX - By Stock
|
32
|
10K
|
4
|
|
ASX - By Stock
|
CDD |
CDD -- The Next Two Years
|
|
sailnyssa
|
32 |
10K |
4 |
01/01/21 |
01/01/21 |
ASX - By Stock
|
32
|
10K
|
4
|
|
ASX - By Stock
|
CDD |
Re:
News: CDD Cardno Sees Fy21 EBITDA In Range Of $40 Million To $45 Million
|
|
sailnyssa
|
43 |
14K |
0 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
43
|
14K
|
0
|
|
ASX - By Stock
|
CDD |
Re:
News: CDD Cardno Sees Fy21 EBITDA In Range Of $40 Million To $45 Million
|
|
sailnyssa
|
43 |
14K |
1 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
43
|
14K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
sailnyssa
|
2.0K |
693K |
7 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
2.0K
|
693K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
sailnyssa
|
13K |
5.0M |
7 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
sailnyssa
|
854 |
431K |
123 |
26/09/20 |
26/09/20 |
ASX - By Stock
|
854
|
431K
|
123
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
sailnyssa
|
17K |
6.8M |
37 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
17K
|
6.8M
|
37
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
sailnyssa
|
17K |
6.8M |
48 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
17K
|
6.8M
|
48
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
sailnyssa
|
17K |
6.8M |
0 |
21/09/20 |
21/09/20 |
ASX - By Stock
|
17K
|
6.8M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
sailnyssa
|
17K |
6.8M |
75 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
17K
|
6.8M
|
75
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
sailnyssa
|
17K |
6.8M |
15 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
17K
|
6.8M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
sailnyssa
|
576 |
234K |
10 |
06/09/20 |
06/09/20 |
ASX - By Stock
|
576
|
234K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
sailnyssa
|
576 |
234K |
1 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
576
|
234K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
W.H.O. confirms that cheap steroids reduce Covid deaths 36%
|
|
sailnyssa
|
58 |
17K |
11 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
58
|
17K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ethics Approval to Treat COVID-19 Patients in Australia
|
|
sailnyssa
|
320 |
129K |
5 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
320
|
129K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ethics Approval to Treat COVID-19 Patients in Australia
|
|
sailnyssa
|
320 |
129K |
4 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
320
|
129K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ethics Approval to Treat COVID-19 Patients in Australia
|
|
sailnyssa
|
320 |
129K |
8 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
320
|
129K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ethics Approval to Treat COVID-19 Patients in Australia
|
|
sailnyssa
|
320 |
129K |
17 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
320
|
129K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
sailnyssa
|
576 |
234K |
3 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
576
|
234K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
sailnyssa
|
576 |
234K |
6 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
576
|
234K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
sailnyssa
|
576 |
234K |
1 |
01/09/20 |
01/09/20 |
ASX - By Stock
|
576
|
234K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
sailnyssa
|
576 |
234K |
8 |
01/09/20 |
01/09/20 |
ASX - By Stock
|
576
|
234K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
sailnyssa
|
576 |
234K |
55 |
01/09/20 |
01/09/20 |
ASX - By Stock
|
576
|
234K
|
55
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
sailnyssa
|
576 |
234K |
23 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
576
|
234K
|
23
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - Most exciting 6 months
|
|
sailnyssa
|
729 |
373K |
112 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
729
|
373K
|
112
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
sailnyssa
|
12K |
6.1M |
3 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
12K
|
6.1M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
(NON-TRADING) COVID-19 ARDS DISCUSSION
|
|
sailnyssa
|
19 |
10K |
2 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
19
|
10K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
(NON-TRADING) COVID-19 ARDS DISCUSSION
|
|
sailnyssa
|
19 |
10K |
8 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
19
|
10K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
sailnyssa
|
13K |
5.0M |
2 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 ARDS and ARDS Share Price Scenarios
|
|
sailnyssa
|
518 |
265K |
1 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
518
|
265K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 ARDS and ARDS Share Price Scenarios
|
|
sailnyssa
|
518 |
265K |
1 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
518
|
265K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 ARDS and ARDS Share Price Scenarios
|
|
sailnyssa
|
518 |
265K |
7 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
518
|
265K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
sailnyssa
|
5.5K |
2.7M |
14 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
5.5K
|
2.7M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
sailnyssa
|
13K |
5.0M |
39 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
39
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
sailnyssa
|
13K |
5.0M |
3 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
sailnyssa
|
13K |
5.0M |
22 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
sailnyssa
|
2.3K |
906K |
0 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
2.3K
|
906K
|
0
|
|